| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 06/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 170 | 80 | 0 | 0 | 0 | 250 |
| 09/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 264 | 0 | 0 | 0 | 0 | 264 |
| 09/08/2021 | instituto butantan | Butantan/CoronaVac | 70 | 0 | 0 | 0 | 0 | 70 |
| 09/08/2021 | JANSSEN | Janssen Covid-19 Vaccine | 20 | 0 | 0 | 0 | 0 | 20 |
| 09/08/2021 | FUNDAÇÃO OSWALDO CRUZ | Fiocruz/Oxford/AstraZeneca | 245 | 0 | 0 | 0 | 0 | 245 |
| 09/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 384 | 0 | 0 | 0 | 384 |
| 09/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 50 | 0 | 0 | 0 | 0 | 50 |
| 11/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 324 | 0 | 0 | 0 | 0 | 324 |
| 11/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 280 | 0 | 0 | 0 | 0 | 280 |
| 13/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 156 | 0 | 0 | 0 | 0 | 156 |
| 16/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 168 | 0 | 0 | 0 | 0 | 168 |
| 16/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 120 | 0 | 0 | 0 | 0 | 120 |
| 18/08/2021 | FUNDAÇÃO OSWALDO CRUZ | Fiocruz/Oxford/AstraZeneca | 0 | 420 | 0 | 0 | 0 | 420 |
| 18/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 80 | 240 | 0 | 0 | 0 | 320 |
| 20/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 264 | 0 | 0 | 0 | 0 | 264 |
| 20/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 150 | 48 | 0 | 0 | 0 | 198 |
| 23/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 170 | 50 | 0 | 0 | 0 | 220 |
| 24/08/2021 | FUNDAÇÃO OSWALDO CRUZ | Fiocruz/Oxford/AstraZeneca | 0 | 670 | 0 | 0 | 0 | 670 |
| 24/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 6 | 0 | 0 | 0 | 6 |
| 24/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 70 | 80 | 0 | 0 | 0 | 150 |
| 24/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 240 | 0 | 0 | 0 | 0 | 240 |
| 27/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 186 | 0 | 0 | 0 | 0 | 186 |
| 30/08/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 48 | 444 | 0 | 0 | 0 | 492 |
| 30/08/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 190 | 120 | 0 | 0 | 0 | 310 |
| 03/09/2021 | INSTITUTO BUTANTAN | Butantan/CoronaVac | 340 | 80 | 0 | 0 | 0 | 420 |
| 06/09/2021 | FUNDAÇÃO OSWALDO CRUZ | Fiocruz/Oxford/AstraZeneca | 0 | 400 | 0 | 0 | 0 | 400 |
| 06/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 198 | 0 | 0 | 0 | 198 |
| 09/09/2021 | CORONAVAC | Butantan/CoronaVac | 130 | 0 | 0 | 0 | 0 | 130 |
| 13/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 204 | 282 | 0 | 0 | 0 | 486 |
| 13/09/2021 | CORONAVAC | Butantan/CoronaVac | 80 | 240 | 0 | 0 | 0 | 320 |
